FILE:JNJ/JNJ-8K-20041006102620.txt.gz
EVENTS:	Other Events
TEXT:
ITEM: Other Events
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 1, 2004 JOHNSON & JOHNSON (Exact name of registrant as specified in its charter) New Jersey 1-3215 22-1024240 (State or other (Commission (I.R.S. Employer jurisdiction File Number) Identification No.) of incorporation) One Johnson & Johnson Plaza, New Brunswick, New Jersey 08933 (Address of principal executive offices) (zip code) Registrant's telephone number including area code: (732) 524-0400 Item 8.01. Other Events On October 1, 2004, Ortho Biotech Products, L.P., a Johnson & Johnson company, issued a press release announcing that it received a subpoena from the Inspector General, Department of Health and Human Services, requesting documents related to the sales and marketing of PROCRITr (Epoetin Alfa). Item 9.01. Financial Statements and Exhibits 9.01(c) Exhibits: Exhibit Number 99.17: Johnson & Johnson Press Release dated October 1, 2004 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. JOHNSON & JOHNSON Date: October 4, 2004 By: /s/ Michael H. Ullmann Michael H. Ullmann Corporate Secretary

Ortho Biotech Products, L.P. Receives Subpoena on PROCRIT(r) BRIDGEWATER, N.J., Oct 1, 2004 -- Ortho Biotech Products, L.P., a Johnson & Johnson company, has received a subpoena from the Inspector General, Department of Health and Human Services, requesting documents related to the sales and marketing of PROCRIT(R) (Epoetin alfa), a prescription treatment for anemia. The company is cooperating in responding to the subpoena.


